Early Mobility Intervention for Critically Ill Children
(PICU Up! Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on early mobility for critically ill children, so it's best to discuss your medications with the trial team.
What data supports the effectiveness of the treatment PICU Up! for critically ill children?
Research suggests that early mobility interventions like PICU Up! can improve outcomes for critically ill children by reducing the duration of mechanical ventilation and enhancing muscle strength, similar to benefits seen in adults. Additionally, implementing early mobility protocols has been associated with improved functional status and increased orders for physical, occupational, and speech therapy, indicating better recovery and quality of life after discharge.12345
Is early mobility intervention safe for critically ill children in the PICU?
How is the PICU Up! treatment different from other treatments for critically ill children?
The PICU Up! treatment is unique because it focuses on early and progressive mobility for critically ill children in the pediatric intensive care unit (PICU), aiming to improve outcomes like reduced mechanical ventilation duration and better functional status. Unlike traditional approaches that often involve sedation and immobilization, this treatment emphasizes individualized physical activities and play to enhance recovery and quality of life.12489
What is the purpose of this trial?
Recent decreases in Pediatric Intensive Care Unit (PICU) mortality rates have been offset by increased morbidity and length of stay for vulnerable young patients. Heavy sedation, bedrest, and delirium contribute to a PICU culture of immobility. While studies in adult ICU patients demonstrate the clinical benefits of early mobilization, fewer than 25% of critically ill children mobilize early in the children's PICU stay. The investigators have demonstrated the safety and feasibility of the 'PICU Up!' Mobility Program, which integrates sleep promotion, delirium prevention, sedation optimization as a bundle to increase mobilization. However, the generalizability and broader impact on patient- and family-centered outcomes is unknown. Therefore, there is an urgent need for trials that blend both clinical effectiveness and implementation research to create a PICU culture of mobility and improve the value of PICU care. The overall objective of the proposed research is to determine the impact of a transdisciplinary and multifaceted early mobility program on clinical outcomes and ICU-acquired morbidities in critically ill children. Additionally, the investigators will identify barriers and facilitators to high-performance bundle adoption.
Research Team
Sapna R Kudchadkar, MD
Principal Investigator
Johns Hopkins University
Eligibility Criteria
This trial is for critically ill children in PICUs that haven't started a mobility program. It's open to all patients admitted, but only those staying 3 days or more are included in the data analysis. Children with an active do-not-resuscitate (DNR) order are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Usual Care
Each unit begins in the baseline, usual care phase before implementing the PICU Up! program
PICU Up! Implementation
Implementation of the PICU Up! program, which includes early mobility interventions, sleep promotion, delirium prevention, and sedation optimization
Post-implementation
Phase following the implementation of the PICU Up! program to assess its impact
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- PICU Up!
PICU Up! is already approved in United States for the following indications:
- Critically ill children requiring early mobility intervention to prevent PICU-acquired morbidities
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Donaghue Medical Research Foundation
Collaborator